Almanack Investment Partners, Llc. Northwest Biotherapeutics Inc Transaction History

Almanack Investment Partners, Llc.

  • $570 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$0.7 - $0.98 $14,000 - $19,600
-20,000 Reduced 47.62%
22,000 $15,000
Q4 2021

Feb 11, 2022
BUY
$0.6 - $1.26 $11,700 - $24,570
19,500 Added 86.67%
42,000 $29,000
Q4 2020

Feb 03, 2021
BUY
$0.73 - $2.3 $16,425 - $51,749
22,500 New
22,500 $34,000

Others Institutions Holding NWBO

# of Institutions
12
Shares Held
625K
Call Options Held
0
Put Options Held
0
View Full List

About NORTHWEST BIOTHERAPEUTICS INC

NWBO Quotes by TradingView
  • Ticker NWBO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,037,230,016
  • Market Cap $446M
  • Description
  • Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, wh...
More about NWBO
Track This Portfolio

Track Almanack Investment Partners, Llc. Portfolio

Follow Almanack Investment Partners, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Almanack Investment Partners, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Almanack Investment Partners, Llc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email